Basic Pharmacokinetic Principles

Fetal and Neonatal Physiology: Third Edition

Volumn 1-2, Issue , 2003, Pages 190-197

  Lugo, Ralph A ^a   Ward, Robert M ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33645020099     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-9654-6.50023-0     Document Type: Chapter

References (18)

1. Gibaldi M, Perrier D Pharmacokinetics 1982, Marcel Dekker, New York.
2. Wilkinson GR Pharmacokinetics: the dynamics of drug absorption, distribution, and elimination. Goodman & Gilman's The Pharmacological Basis of Therapeutics 2001, 3-29. McGraw-Hill, New York. J.G. Hardman (Ed.).
3. Krzyzanski W, Jusko WJ Application of moment analysis to the sigmoid effect model for drug administered intravenously. Pharm Res 1997, 14:949.
4. Cheng H, Jusko WJ Noncompartmental determination of the mean residence time and steady-state volume of distribution during multiple dosing. J Pharm Sci 1991, 80:202.
5. Notari RE Rate processes in biological systems. Biopharmaceutics and Clinical Pharmacokinetics: An Introduction 1980, 5-44. Marcel Dekker, New York. 3rd ed.
6. Greenblatt DJ, Koch-Weser J Clinical pharmacokinetics. N Engl J Med 1975, 293:702.
7. Galinsky RE, Svvensson CK Basic pharmacokinetics. Remington: The Science and Practice of Pharmacy 1995, Vol 1:724-760. Mack Publishing, Easton, MD. A.R. Gennaro (Ed.).
8. Zaske DE Aminoglycosides. Applied Pharmacokinetics: Principles of Therapeutic Drug Monitoring 1992, 1-14. Applied Therapeutics, Vancouver, WA. W.E. Evans (Ed.).
9. Matzke G Vancomycin. Applied Pharmacokinetics: Principles of Therapeutic Drug Monitoring 1992, 11-15. Applied Therapeutics, Vancouver, WA. W. Evans (Ed.).
10. Ward RM Pharmacologic principles and practicalities. Avery's Diseases of the Newborn 1998, 404-412. WB Saunders Co, Philadelphia. H.W. Taeusch, R.A. Ballard (Eds.).
11. Hastreiter AR, et al. Maintenance digoxin dosage and steady-state plasma concentration in infants and children. J Pediatr 1985, 107:140.
12. Heizmann P, et al. Pharmacokinetics and bioavailability of midazolam in man. Br J Clin Pharmacol 1983, 16(Suppl 1):43S.
13. Paine MF, et al. First-pass metabolism of midazolam by the human intestine. Clin Pharmacol Ther 1996, 60:14.
14. de Wildt SN, et al. Pharmacokinetics and metabolism of oral midazolam in preterm infants. Br J Clin Pharmacol 2002, 53:390.
15. Penson RT, et al. The bioavailability and pharmacokinetics of subcutaneous, nebulized and oral morphine-6-glucuronide. Br J Clin Pharmacol 2002, 53:347.
16. Borchard U Pharmacokinetics of beta-adrenoceptor blocking agents: clinical significance of hepatic and/or renal clearance. Clin Physiol Biochem 1990, 8(Suppl 2):28.
17. DiPiro JT, et al. Concepts in Clinical Pharmacokinetics 1996, American Society of Health-System Pharmacists, Bethesda, MD. 2nd ed.
18. Bouroujerdi M Pharmacokinetics: Principles and Applications 2002, 205-231. McGraw-Hill, New York.